COX-2 and cancer: a new approach to an old problem

被引：106
作者：
Bakhle, YS [1 ]
机构：
[1] Univ London Imperial Coll Sci & Technol, Fac Med, Div Biomed Sci, London SW7 2AZ, England
来源：
BRITISH JOURNAL OF PHARMACOLOGY | 2001年 / 134卷 / 06期
关键词：
angiogenesis; APC; apoptosis; aspirin; breast; (cancer); carcinogenesis; chemoprevention; chemotherapy; colorectal; (cyclo-oxygenase); cytokines; epidemiology; FAP; HNPCC; lung; Min mouse; NSAID; PPAR; prostate; sulindac; thiazolidinedione;
D O I：
10.1038/sj.bjp.0704365
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：1137 / 1150
页数：14
相关论文
共 50 条
  • [41] COX-2 expression pattern is related to ovarian cancer differentiation and prognosis, but is not consistent with new model of pathogenesis
    Magnowska, Magdalena
    Zaborowski, Mikolaj
    Surowiak, Pawel
    Nowak-Markwitz, Ewa
    Zabel, Maciej
    Spaczynski, Marek
    GINEKOLOGIA POLSKA, 2014, 85 (05) : 335 - 341
  • [42] Survivin expression in in situ and invasive breast cancer relates to COX-2 expression and DCIS recurrence
    N Barnes
    P Haywood
    P Flint
    W F Knox
    N J Bundred
    British Journal of Cancer, 2006, 94 : 253 - 258
  • [43] Prevention of colorectal cancer through the use of COX-2 selective inhibitors
    Richard M. Peek
    Cancer Chemotherapy and Pharmacology, 2004, 54 : S50 - S56
  • [44] COX-2 Expression Does Not Correlate with Microvessel Density in Breast Cancer
    Thorat, Mangesh A.
    Mehrotra, Sanjana
    Morimiya, Akira
    Badve, Sunil
    PATHOBIOLOGY, 2009, 76 (01) : 39 - 44
  • [45] Resistance of prostate cancer cell lines to COX-2 inhibitor treatment
    Wagner, M
    Loos, J
    Weksler, N
    Gantner, M
    Corless, CL
    Barry, JM
    Beer, TM
    Garzotto, M
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 332 (03) : 800 - 807
  • [46] Usefulness of selective COX-2 inhibitors as therapeutic agents against canine mammary tumors
    Saito, Teruyoshi
    Tamura, Dai
    Asano, Ryuji
    ONCOLOGY REPORTS, 2014, 31 (04) : 1637 - 1644
  • [47] Expression of COX-2 and Bcl-2 in primary fallopian tube carcinoma: correlations with clinicopathologic features
    Wang, Fang
    Sun, Guo-Ping
    Zou, Yan-Feng
    Wu, Qiang
    Wu, Hong-Yang
    Wu, Ji-Feng
    Zhous, Jia-De
    Chen, Ke
    Zhang, Xiu-Shan
    FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, 2011, 49 (03) : 389 - 397
  • [48] Selective COX-2 inhibitors do not increase gastrointestinal reactions after colorectal cancer surgery: a systematic review and meta-analysis
    Hu, Ting
    Liu, Cheng-Jiang
    Yin, Xiaoming
    Tang, WenJuan
    Yin, LanFang
    Bai, Hui
    Liu, FangFang
    Wang, Dan
    Li, YiLei
    BMC GASTROENTEROLOGY, 2023, 23 (01)
  • [49] Mucosal repair and COX-2 inhibition
    Perini, RF
    Ma, L
    Wallace, JL
    CURRENT PHARMACEUTICAL DESIGN, 2003, 9 (27) : 2207 - 2211
  • [50] Participation of COX-1 and COX-2 in the contractile effect of phenylephrine in prepubescent and old rats
    Guevara-Balcazar, Gustavo
    Ramirez-Sanchez, Israel
    Mera-Jimenez, Elvia
    Rubio-Gayosso, Ivan
    Eugenia Aguilar-Najera, Maria
    Castillo-Hernandez, Maria C.
    KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY, 2017, 21 (04) : 407 - 413
12345